We previously reported that mitochondrial CYP1 enzymes participate in the metabolism of polycyclic aromatic hydrocarbons and other carcinogens leading to mitochondrial dysfunction. In this study, using Cyp1b1 À/À , Cyp1a1/1a2
Chronic pancreatitis is a precursor for pancreatic ductal adenocarcinoma (PDA), which carries with it a poor 5-year survival rate. Epidemiological and clinical studies suggest a strong correlation between cigarette smoking and PDA (Edderkaoui and Thrower, 2013; Wittel et al., 2008) ; Cigarette-smoking is considered to be a major risk factor associated with chronic pancreatitis (Edderkaoui and Thrower, 2013) . The disease is often associated with activation of proteases, and increased expression of an array of pro-inflammatory genes such as COX2, Interleukin-1b, and NF-jB (Duell, 2012; Wittel et al., 2006a Wittel et al., , 2008 . Of the myriad of chemicals in cigarette smoke, over 60 compounds have been identified as potential carcinogens (Hecht, 1999; Lynch et al., 2009) . These compounds could be acting independently or synergistically to induce pancreatitis and cancer.
Several studies have also suggested that tobacco smoking in combination with alcohol consumption is a powerful driver of pancreatitis and cancer (Chowdhury and Udupa, 2006; Talamini et al., 1999) . These studies suggest that alcohol is only able to augment pancreatitis initiated by toxic products present in cigarette smoke (Herreros-Villanueva et al., 2013) . We therefore initiated this study to understand the mechanism of cigarette toxin-induced pancreatitis (Apte et al., 2010; Chowdhury and Udupa, 2006; Duell, 2012; Edderkaoui and Thrower, 2013; Talamini et al., 1999) .
Currently, there is very little information on the biochemical and cellular pathways of cigarette toxin-induced pancreatitis. Although several studies suggest that intra-acinar trypsinogen activation is a critical event, the precise causative factor(s), as to whether protease stimulation or inflammatory response drive the disease state, remains unclear. It is widely believed that the aberrant release of cytokines, as well as cholecystokinin, lead to uncontrolled acinar cell stimulation and activation of digestive proteases as pivotal in the pathogenesis of pancreatitis (Pandol et al., 2007) . Accordingly, cerulein, an analog of cholecystokinin, induces chronic pancreatitis in rodents (Dawra et al., 2007; Foitzik et al., 2000; Gukovsky et al., 1998; Makhija and Kingsnorth, 2002; Pandol et al., 2003) .
Benzo [a] pyrene (BaP) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) are powerful activators of aryl hydrocarbon receptor (AhR), which in turn induces the expression of members of cytochrome P450 family 1 (Cyp1) genes. Specifically, three orthologs of Cyp1 gene family, Cyp1a1, Cyp1a2, Cyp1b1, in addition to several phase 2 drug metabolizing enzymes, involved in the metabolism/elimination of diverse polycyclic aromatic hydrocarbons (PAHs) are induced by AhR (Denison and Nagy, 2003; Guengerich and Shimada, 1998) in the lung, skin, brain, intestine, and bone marrow cells. Based on studies in genetically engineered mouse models, the AhR has been reported to affect a multitude of pathophysiological functions; including PAHinduced carcinogenesis and inflammatory response (Hankinson, 1995; Nebert et al., 2000; Wilson and Safe, 1998) . Recent studies further revealed the role of AhR in osteogenesis and PAH-induced osteoclastogenesis (Galvan et al., 2003 (Galvan et al., , 2005 Iqbal et al., 2013; Voronov et al., 2005) . AhR is also known to induce the expression of an array of cytokines and chemokines that are involved in inflammatory and immune responses (Denison and Nagy, 2003; Hankinson, 1995; Nebert and Karp, 2008) , and also several class II drug metabolizing enzymes that are generally involved in drug detoxification (Schrenk, 1998) .
In this study, we used Cyp1b1
, and Cyp1a1/1a2/1b1 À/À mice to study the role of BaP and TCDD in inducing pancreatitis. We also tested the effects of resveratrol, a natural compound, and an important component of food material, which is also known for its AhR antagonistic effects, and antioxidant activity (Casper et al., 1999; Revel et al., 2003) . We show that both BaP and TCDD, cause pathological symptoms and induce markers characteristic of pancreatitis. We further show that BaP and TCDD alter the AhR-mediated expression of Cyp1 genes, which in turn induce pancreatic mitochondrial respiratory stress and oxidative stress. Our results show that CYP1-mediated mitochondrial dysfunction is associated with BaP-and TCDD-induced pancreatitis.
MATERIALS AND METHODS

Mouse models
Wild-type (WT), Cyp1a1/1a2
(triple KO), and Cyp1b1 À/À mice were used to evaluate the roles of these CYPs in mitochondrial respiration and electron transport chain complex activities from untreated and treated animals. The construction of mouse strains Cyp1b1
, and Cyp1a1/1a2/1b1 À/À were published earlier (Buters et al., 1999; Rouillon et al., 1991) . For studying mitochondrial respiratory patterns, we developed a procedure for isolating actively respiring mitochondria from mouse pancreatic tissues. Male and female mice aged (6-8 weeks) were divided into five different groups. Group-I (controls) received corn oil only. Group-II animals were treated with BaP (120 mg/kg body weight in corn oil) once a day for 6 days by oral gavage, which was shown to be most effective way mimicking the inhaled cigarette smoke (Uno et al., 2008) . However, oral gavaging of TCDD was less effective as compared with ip injection (Uno et al., 2008) . TCDD (30 lg/kg body weight in DMSO) was administered intraperitoneally once a day for 3 days. Group-III mice were treated with BaP or TCDD (as above) plus resveratrol (20 mg/kg body weight). Group IV consisted of resveratrol only (20 mg/kg) administered orally for 6 days to control mice. Group V consisted of control mice treated with DMSO only orally for 6 days. The dosage and time points for BaP or TCDD treatment in vivo were based on the literature, and our own published studies (Bansal et al., 2014; Dong et al., 2009; Iqbal et al., 2013) . The resveratrol dose was based on Jang et al. (1997) and Yang et al. (2007) . In all cases, vehicle control, corn oil was administered orally or intraperitoneally as appropriate. Mice were euthanized by CO 2 asphyxiation protocol using a Crainey Tech asphyxiation chamber in accordance with the American Veterinary Medical Association (AVMA) and National Institutes of Health (NIH) approved guidelines and a Protocol approved by the Institutional Animal Care and Usage Committee at the University of Pennsylvania. Pancreas tissues from control and treated mice were collected and used for preparing subcellular fractions for further studies. A portion of the tissue in each case was fixed in paraformaldehyde-picric acid preservative (Stefanini et al., 1967) for histopathological studies as described later, and another portion was used for isolating total RNA.
Reagents
The Amylase assay kit from Diagnostic Chemicals (Charlottetown, Canada) was used. BaP, TCDD, DMSO, catalase, ubiquinol, ADP, sodium succinate, NADH, cytochrome C, lauryl maltoside, oligomycin, 2,4-dinitrophenol (DNP), rotenone, antimycin, CH223191, and resveratrol were of highest available purity, obtained from Sigma Chemical Co. (St Louis, MO).
Isolation of respiratory competent mitochondria from mouse pancreas
The procedure for mitochondrial isolation from pancreatic tissue was modified from that reported for the liver tissues (Niranjan et al., 1984) . Pancreatic tissue was rapidly harvested and transferred to ice-cold PBS, containing 0.25 mg/ml of soybean trypsin inhibitor. Excess blood was washed off and the tissue was finely minced in 3-to 4-ml ice cold H-medium (70 mM sucrose/210 mM mannitol/1 mM EGTA/10 mM HEPES-KOH, pH 7.3) containing 0.5% bovine serum albumin (BSA), soybean trypsin inhibitor (0.25 mg/ml); 1 mg/ml each of pepstatin, aprotinin, leupeptin, and 1 mM PMSF. The minced tissue was homogenized with 10-12 strokes in a Dounce Glass homogenizer using Type A pestle. The homogenate was diluted with 3-fold excess ice-cold H-medium with protease inhibitor supplements and centrifuged at 1000 Â g for 10 min to remove cell debris and nuclei. This step was repeated to remove any remaining debris. The supernatant was then centrifuged at 7000 Â g for 15 min to pellet crude mitochondria. The mitochondrial pellet was washed with excess H-medium without BSA. The final pellet was resuspended in small volume (25-400 ml) of H-medium and used immediately for respirometry or stored in aliquots at À80 C for biochemical analyses.
Assay of cytochrome c oxidase activity
Complex IV (Cytochrome c Oxidase, CcO) activity was measured by incubating 2-10 lg of freeze-thawed mitochondrial extract in 1 ml of assay medium (25 mM potassium phosphate, pH 7.4, and 0.45 mM dodecylmaltoside). Ferro-cytochrome c (15 lM) was added, and reaction rates were measured using a Cary-1E spectrophotometer. First-order rate constants were calculated based on regression analysis, using the Cary-Win kinetics software. The molar extinction co-efficient (e) of 21.1 was used for the conversion of OD units to molar amounts of reduced cytochrome c oxidized as described previously (Bansal et al., 2014; Raza et al., 2011) .
Measurement of mitochondrial respiration
Seahorse XF24 Extracellular Flux Analyzer (Seahorse Biosciences, North Billerica, MA) was used to assess the mitochondrial respiratory function. Freshly isolated mitochondria (10 lg/well) from control and treated mouse pancreas were plated onto poly-L-lysine coated Seahorse plates. Mitochondria were energized by adding 8 mM succinate. Respiration was sequentially measured in energized mitochondria (basal respiration), followed by state 3 (phosphorylating respiration), in the presence of 4 mM ADP, state 4 (resting respiration) after addition of 2.5 lg/ml oligomycin, an inhibitor of mitochondrial ATPase. Uncoupled maximal respiration was determined by adding 150 lM DNP or 4 lM FCCP as mentioned in figure legends. Finally, complex III inhibitor antimycin A (4 lM) was added for measuring non-mitochondrial respiration. Results represent O 2 consumption/min/mg mitochondrial protein.
Quantification of mRNA and mitochondrial DNA content
Total RNA was isolated from fresh pancreatic tissues using TRIzol reagent (Invitrogen), according to the manufacturer's recommended protocol. For real-time PCR analysis, RNA was digested with turbo DNase I (Ambion, Inc), and cDNA was synthesized using 1 lg total RNA as template by using the High Capacity cDNA Archives kit (Applied Biosystems, Inc). Relative Cyp1a1, Cyp1a2, Cyp1b1 mRNAs and, cytokines and chemokines mRNA levels were measured by standard SYBR Green real-time PCR on an Quant Studio 6 real-time PCR machine (Applied Biosystems, Thermos Fisher) as described before (Bansal et al., 2010) . Primer sequences are listed in Table 1 . The experimental Ct values were normalized with the b-actin mRNA or 18 s rRNA and expressed as fold increase over untreated or vehicle treated controls. Mitochondrial DNA from pancreatic tissues was quantitated by long Amplicon PCR of total tissue DNA as template that is based on the principle that the DNA templates with oxidative/ chemical damages hinder the progression of chain elongation by DNA polymerase and consequently serve as poor templates for amplification. The use of specific primers and PCR conditions were as described by Bansal et al. (2014) .
Histology and immunohistochemistry
After fixation 5-mm sections of pancreatic tissue samples were stained with haematoxylin/eosin and examined by a pathologist. The extent of acinar cell injury or necrosis was quantified by computer-assisted morphometry, as previously described by Bhatia et al. (1998) . For the morphological examination, 10 microscopic fields were randomly chosen for each tissue Table 1 . List of Primers Used for Quantitation of mRNA by Real-Time PCR Interleukin-1 beta F.P-CCATGGCACATTCTGTTCAAA R.P-GCCCATCAGAGGCAAGGA Interferon-gamma F.P-ACAATGAACGCTACACACTGCAT R.P-TGGCAGTAACAGCCAGAAACA Interleukin-6 F.P-TTCCATCCAGTTGCCTTCTTG R.P-GGGAGTGGTATCCTCTGTGAAGTC Interleukin-10 F.P-CAGCCGGGAAGACAATAACTG R.P-CCGCAGCTCTAGGAGCATGT Interleukin-12 alpha F.P-AAGCTCTGCATCCTGCTTCAC R.P-GATAGCCCATCACCCTGTTGA TGF-beta1
F.P-GCGACGATTCCTCCGGGCTG R.P-GGCCTGAACATCCGGGTATCTGGT specimen, and a representative image in each case has been presented.
SDS-PAGE and immunoblot analysis
For SDS-PAGE analysis, mitochondrial proteins were resolved on 12% SDS-polyacrylamide gels. Proteins were then transferred to nitrocellulose membranes (Bio-Rad), and probed with the appropriate antibodies. Antibodies specific for CcOIVi1 (ab110272), CcO Vb (ab110263), and succinate dehydrogenase complex flavoprotein subunit A (SDHA) (ab14715) were obtained from Abcam (Cambridge, MA). Antibodies for CYP1A1 (sc-25304), CYP1A2 (sc-30085), CYP1B1 (sc-32882), and NADPH-P450 oxidoreductase (NPR) (sc-25270) were purchased from Santa Cruz Biotechnology, Inc (Dallas, TX). Blots were probed with appropriate dilutions of primary antibody (final concentration $1 lg/ml) followed by corresponding secondary antibodies
(1:10000) that were infrared-tagged and imaged through an Odyssey image scanner and analyzed by Odyssey Infrared Imaging System application software (LiCor, Inc, Lincoln, NE).
Amylase assay
Serum a-amylase activity was measured using 4,6-ethylidene-(G7)-1,4-nitrophenyl-(G1)-a-D-maltoheptoside as a substrate, as described by Kruse-Jarres et al. (1989) .
Statistical analysis
The means 6 SEM were calculated from 3-to 5-independent experiments. Group differences were assessed by one-way analysis of variance (ANOVA) or unpaired two-tailed Student's t test, where necessary with Tukey's multiple comparisons test for multiple comparisons. Differences were considered significant at p .05.
RESULTS
Effects of BaP on Cyp1a1/1a2 and 1b1 Gene Expression in the Pancreatic Tissue
There is limited information on Cyp1 gene expression and its role in PAH-induced toxicity in the pancreas (Crous-Bou et al., 2008; Pavek and Dvorak, 2008) . We therefore investigated levels of three Cyp mRNAs, Cyp1a1, 1a2, and 1b1 in WT and Cyp1b1
À/À mice treated with or without BaP administered with corn oil as vehicle. Figures 1A and 1B show the levels of induction of Cyp1a1, Cyp1a2, and Cyp1b1 mRNAs in control and BaP-treated mouse pancreas from WT and Cyp1b1 À/À mice, respectively.
Cyp1a1 and Cyp1b1 mRNAs were induced by about 2.5-to 3-fold of control levels in WT mice. Consistent with what has been reported in other rodent tissues, Cyp1a2 mRNA was not induced significantly by BaP suggesting that AhR is not a major factor regulating the expression of this gene in the pancreas as well. In Cyp1b though it could be because of unknown compensatory effect. As expected, there was no measurable induction of Cyp1b1 mRNA in these mice. Treatment with resveratrol along with BaP markedly diminished the induction of both Cyp1a1 and Cyp1b1 mRNAs in WT mice and also, induction of Cyp1a2 mRNA in Cyp1b1 À/À mice. A similar pattern of high level induction of 1a1 mRNA in the lungs of Cyp1b1 À / À mice was reported (Bansal et al., 2014; Galvan et al., 2005) . Quantitative PCR data in Figures 1C and 1D further support that pancreatic Cyp1b1 expression in response to BaP was very high ($13 fold) in Cyp1a1/1a2 À/À mice, whereas Cyp1a1 mRNA expression was $17 fold in Cyp1b1 À/À mice. Furthermore, in both cases the BaP-induced expression was sensitive to the potent and specific AHR antagonist CH223191. Consistent with the mRNA induction, immunoblot in Figure 1E shows that the CYP1A1 and CYP1B1 protein levels were also increased in BaP-treated WT mice ( Figure 1E ). The minor band in Cyp1b1 À/À mice could be due to a non-specific antibody cross-reactivity. Immunoblot in Figure 1F shows that Cyp 1B1 protein was induced marginally in WT mice by BaP treatment, whereas the induction was several folds higher in Cyp1a1/1a2 À/À mice. Antibody against the microsomal protein NADPH-p450 reductase (NPR) was used for protein loading control. These results not only confirm that the major PAH metabolizing enzymes CYP1A1 and CYP1B1 are expressed in the pancreas, but also are induced by BaP in an AhR-dependent manner Dong et al., 2009 ).
BaP-Induced Mitochondrial Respiratory Defects and Attenuation by Resveratrol
The respiratory profiles were measured in the Seahorse XF-24 analyzer (Figs. 2A and 2B) as described in the Materials and Methods section (Wu et al., 2007) . Results show that BaP treatment in WT mice significantly reduced the basal respiration, ADP-coupled respiration, and also maximal uncoupled respiration. All these respiratory parameters were reversed by resveratrol treatment (Figs. 2A, 2C-E). Using this approach, we also measured the effects of BaP treatment on respiration profiles of pancreatic mitochondria from wild-type, Cyp1b1 À/À , Cyp1a1/ 1a2 À/À , and Cyp1a1/1a2/1b1 À/À mice to determine if BaP-induced respiratory dysfunction required CYP1 function. These results show that BaP treatment significantly reduced the maximal respiration (after addition of DNP) as well as state 3 respiration in wild-type, and Cyp1b1 À/À mice, but had relatively little effect in Cyp1a1/1a2 À/À and Cyp1a1/1a2/1b1 À/À mice ( Figs. 2A-C) . This suggests that BaP-induced respiratory impairment requires CYP1B1 and CYP1A1 expression and function. Resveratrol, a known AHR antagonist is also known to have protective effects on brain mitochondrial function (Ferretta et al., 2014; Lagouge et al., 2006) . We tested the direct effects of resveratrol on mitochondrial respiratory parameters in WT mice. The respiration pattern in Figure 3A shows that state 3 respiration was marginally ($10%) increased and state 4 respiration was marginally decreased ($5%) by resveratrol. Results in Supplementary Figure 1 show no significant effects on CcO activity, complex I activity and also subunit IVi1 and Vb levels ( Supplementary Figs. 1A and 1B) . We also did not observe any measurable increase in the expression of Cyp1A1 and 1B1 protein levels in WT pancreas ( Supplementary Figs. 1A-C) . Considering that resveratrol treatment rendered nearly 50%-60% protection in BaP-treated WT and 1b1 À/À mice, these results suggest that the direct effect of resveratrol contributed only marginally to the respiratory protection against BaP treatment. Taken together, our results show that protection against BaP-induced mitochondrial defect by resveratrol is largely due to its antagonistic action on AHR.
Effects of BaP on Pancreatic Mitochondrial Electron Transport Complex Activity
We investigated the effects of BaP on cytochrome c oxidase (CcO, complex IV), the terminal oxidase of the mitochondrial electron transport chain, which was also shown to be the major target of BaP in the liver and lung (Bansal et al., 2014) . Figure 4A shows that CcO activity was inhibited significantly ($45%) in the BaP-treated pancreatic tissues from WT mice and marginally ($25%) in Cyp1b1 À/À and Cyp1a1/1a2 À/À mice, whereas no significant inhibition occurred in Cyp1a1/1a2/1b1 À/À mice ( Figure 4A ). Immunoblotting shows the relative levels of nuclear coded subunits, CcO IVi1 and Vb, which was previously shown to be susceptible to degradation in BaP-treated mouse lungs ( Figure 4B ). Figure 4C shows the relative mtDNA content in WT and Cyp KO mice treated with or without BaP. The data on mtDNA contents are similar to the results of CcO activity ( Figure 4A ) in that both DKO and TKO mice showed moderate to no effect by BaP treatment. The reasons for significantly reduced CcO activity and mtDNA content in untreated Cyp1b1 in the Cyp1a1/1a2/1b1 À/À mice, which underscores the role of CYP1 in BaP-mediated toxic effects on mitochondrial function. Figure 5 shows the histopathology of pancreatic sections of mice treated with vehicle alone, BaP and BaP plus resveratrol. Pancreatic tissues from mice treated with vehicle alone show no detectable pathology, whereas those treated with BaP show signs of immune cell infiltration and acinar cell degradation ( Figure 5A ). These are classic signs of acute pancreatitis. Interestingly, tissues from mice co-administered with resveratrol showed considerably less acute pancreatitis. Figure 5B shows that BaP treatment alone induces serum a-amylase, which is a marker of pancreatic acinar cell damage. Co-treatment with resveratrol significantly reduced the serum a-amylase level, suggesting a potential protective effect by this AhR antagonist.
BaP Treatment Induces Pancreatitis
TCDD-Induced Pancreatic Lesions and Attenuation by Resveratrol
Previous studies demonstrated that TCDD affected mitochondrial function (Biswas et al., 2008) and induced stress signaling in an AhR-independent mechanism (Hwang et al., 2016) . We investigated the effects of TCDD on mitochondrial respiratory function and induction of pancreatitis. Figure 6A shows that TCDD treatment markedly reduced the basal respiration, ADP-coupled respiration and also maximal respiration (Figs. 6A-D) . Resveratrol dramatically reversed all the respiratory parameters (Figs. 6A-D) . CcO activity was markedly inhibited by TCDD that was modestly reversed by resveratrol ( Figure 6E ). Inefficient reversal by resveratrol likely represents the AhR-independent direct binding of TCDD to membrane complexes (Biswas et al., 2008) . The histopathological parameters presented in Figure 7A show that similar to BaP-, TCDD-induced acute pancreatitis, which was attenuated by resveratrol. Consistent with these results, amylase levels were induced by TCDD and were attenuated by co-treatment with resveratrol ( Figure 7B ). Thus, BaP and TCDD induce pancreatitis, which is associated with mitochondrial dysfunction. The infiltrating cells shown in the middle panel of Figure 7A are mostly seen in TCDD-treated mouse pancreas, but not in control or resveratrol co-treated mice. Similarly, both treated and untreated Cyp1a1/1a2 À/À and 1b1 À/À mice showed no detectable infiltrating cells. Although not shown, their histopathology patterns looked indistinguishable from untreated WT mouse pancreas.
Role of Cyp1 Gene Expression on BaP-Induced Cytokine Expression
Recent studies indicate an intimate connection between mitochondrial function and inflammatory and immune responses ( Gukovskaya et al., 2017) . Mitochondrial dysfunction was shown to induce various pro-and anti-inflammatory cytokines and influence inflammation. Among pro-inflammatory cytokines, Il-6 is considered a key player in pancreatitis and potential therapeutic target (Zhang et al., 2013) . Analysis of pancreatic tissues revealed that some of these cytokine mRNAs including Il6, Il12, Il1b, and tnfa are present at higher levels in BaP-treated WT and Cyp1b1 À/À mice (Figs. 8A and 8B ). The chemokine CCL5 (C-C motif ligand 5) and it's receptor, CCR5 are believed to be involved in chronic pancreatitis (Goecke et al., 2000) . The higher level of Ccr5 mRNA expression in WT and Cyp1b1 À/À mice support the previous finding where CCR5 may offer pancreatic cells protection from the damaging effects of cigarette smoking (Duell et al., 2006) . Figure 8A shows that Il6, Il12, Il1b, Tnfa, and Ccr5 mRNAs were induced by BaP treatment in WT mouse pancreas that was attenuated by co-treatment with resveratrol. By contrast, Il10 and Infg mRNAs were induced by resveratrol alone to offer protection from BaP damage in pancreatic cells. All these cytokines were also induced in Cyp1a1/1a2 À/À mice, although at a significantly lower level and the induction was reversed by resveratrol. However, only Infg mRNA was induced by BaP in Cyp1a1/ 1a2 À/À mice and Tgfb mRNA was induced in Cyp1b1 À/À and Cyp1a1/1a2/1b1 À/À mice. Thus, we demonstrated a novel role for CYP1 enzymes in BaP-mediated induction of certain cytokines.
DISCUSSION
Multiple epidemiological and experimental studies have established cigarette smoking as a risk factor for pancreatic cancer development and promotion (Lowenfels and Maisonneuve, 2003; Maisonneuve and Lowenfels, 2010) . Nearly 25% of PDA deaths are associated with tobacco smoke and depending on the duration and intensity of smoking, the risk of PDA can be even higher (Iodice et al., 2008) . Despite the identification of various causative agents and carcinogens in the cigarette smoke, the underlying mechanisms of cigarette smoke-induced pancreatitis and pancreatic cancer is still not clear. Some of the most studied carcinogens such as Nicotine-derived nitrosamine ketone (NNK), BaP and other nicotine derivatives have been shown to modify inflammatory responses, cell signaling and the extent of damage in apoptotic/necrotic pancreatic cells (Duell, 2012; Edderkaoui and Thrower, 2013; Wittel et al., 2006a,b) . BaP is metabolized by CYP1 enzymes and affects AhR-induced transcriptional regulation of Cyp1 genes (Tai et al., 2007) . Whereas TCDD is refractory to CYP-mediated metabolism, it is a potent activator of AhR (Denison and Nagy, 2003; Hassoun et al., 2002) . In this study using Cyp1a1/1a2 À/À and Cyp1a1/1a2/1b1 (Bansal et al., 2014) . The pancreas of treated mice clearly showed morphological damage in acinar cells and demonstrated increased inflammatory cytokine-producing cells. Increased release of a-amylase in serum of BaP-treated mice also suggests pancreatitis. The induction of Cyp1a1 mRNA and resulting enzyme activity has long been used as a sensitive indicator of AhR activation in numerous in vitro and in vivo models for screening a variety of compounds and environmental toxicants (Behnisch et al., 2001) . A strong correlation between AhR binding affinity of the promoter sites, Cyp1b1/1a1 induction, and dioxin-like toxicity of structurally related PAHs, has been used as a biomarker for hazard identification and risk assessment of environmental pollutants, industrial chemicals, and therapeutic compounds (Behnisch et al., 2001 (Behnisch et al., , 2002 . This study also points to novel aspects of mitochondrial respiratory controls and electron transfer complexes as possible targets of AhR. In this study, we show that BaP treatment not only inhibits mitochondrial oxygen consumption, but also affects mitochondrial DNA content and electron transport chain complexes.
Recent studies suggest that several PAH compounds present in environmental pollution and cigarette smoke induce the expression of cytokines and chemokines that are associated with inflammatory tissue damage (Goulaouic et al., 2008; van der Vaart et al., 2004) . Some of these same cytokines IL-6, IL-12, IL-b, TNF-a, and CCR5, as well as the receptor for cytokine CCL5 are induced in the pancreatic tissue following BaP treatment. A notable observation in this study is that the expressions of a number of these cytokine mRNAs are dependent on the presence of one or the other CYP1 enzymes. Although the precise mechanism of induced expression of these cytokines under our experimental system remains to be elucidated, we propose that the CYP1 enzyme-mediated metabolites of BaP or their levels may be involved in this process in WT mice. Resveratrol is a naturally occurring dietary polyphenolic compound present in grapes, peanuts, berries, and several plants used in traditional Asian medicine (Aziz et al., 2003; Jayatilake et al., 1993) . Resveratrol has been shown to act as an AhR antagonist and inhibits the expression of a number of CYP genes, including PAH inducible CYP1 family members and other CYPs and hence enables chemopreventive activity (Aluru and Vijayan, 2006; Casper et al., 1999; Chang et al., 2001; Chen et al., 2004; Piver et al., 2001) . Some studies also suggest that resveratrol plays a positive role in mitochondrial functional integrity by way of inducing CIRT1 and PGC1a family transcription factors that are known to be the master regulators of mitochondrial biogenesis (Ferretta et al., 2014; Lagouge et al., 2006) . Using transgenic mouse models, our results showed a marked reversibility of BaP-and TCDD-induced mitochondrial function and infiltration of immune cells in the pancreatic tissue by resveratrol. Based on our results showing the need for Cyp1 gene expression and Cyp1 enzymes for inducing pathology, we believe that resveratrol-mediated protection in our experimental system largely stems from its antagonistic effect of AhR. Present results with Cyp1 transgenic knock out mice also suggest that the metabolic activities of mitochondrial Cyp1 enzymes may also be involved in inducing mitochondrial ROS production and associated mitochondrial dysfunction.
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